Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
B-Cell Lymphoma
New B-cell lymphoma data have been reported by researchers at University of Bologna
May 20th, 2008
According to recent research published in the journal Annals of Oncology, "A prospective, single-arm, open-label, nonrandomized phase II combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus radioimmunotherapy trial was conducted to evaluate the efficacy and safety in untreated elderly diffuse large B-cell lymphoma (DLBCL) patients. From February 2005 to April 2006, in our institute we treated 20 eligible elderly (age >= 60 years) patients with previously untreated DLBCL using a novel regimen consisting of six cycles of CHOP chemotherapy followed 6-10 weeks later by Y-90 ibritumomab tiuxetan." "The overall...
Source: Cancer Weekly (2008-05-20)
|
